FLAC

NASDAQ

Frazier Lifesciences Acquisition Corporation

SectorFinanceIndustryBusiness ServicesIPO2021

News25/Ratings0

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Latest news

25 items

1163d13D/G
SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
SC 13G/A - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1238dSEC
SEC Form 15-12G filed by Frazier Lifesciences Acquisition Corporation
15-12G - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)
1239d13D/G
SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
SC 13G/A - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1245d13D/G
SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
SC 13D/A - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1245dINSIDER
SEC Form 4 filed by Viking Global Investors Lp
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247dSEC
Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)
1247dINSIDER
SEC Form 4 filed by Topper David Joseph
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247dINSIDER
SEC Form 4 filed by Bigham Michael
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247dINSIDER
SEC Form 4 filed by Polu Krishna R
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247dINSIDER
SEC Form 4 filed by Baltera Robert Jr.
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247dINSIDER
SEC Form 4 filed by Gallagher Carol Giltner
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1247d13D/G
SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
SC 13D/A - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1248dSEC
SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation
25-NSE - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1248dSEC
SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation
25-NSE - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1248dSEC
SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation
25-NSE - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1255dSEC
Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)
1255dNEWS
Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination With NewAmsterdam Pharma Holding B.V.
Frazier Lifesciences Acquisition Corporation (NASDAQ:FLAC) (“FLAC”), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its shareholders voted to approve the proposed business combination (the “Business Combination”) with NewAmsterdam Pharma Holding B.V. (“NewAmsterdam”), a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. More than 90% of the votes cast at the Extraordinary General Meeting of Shareholders (the “General Meeting”) were cast in favor of the previously announced business combination. FLAC shareholders also voted to approve all
1256dINSIDER
SEC Form 3: New insider Flynn James E claimed ownership of 2,480,199 units of Class A Ordinary Shares
3 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1256d13D/G
SEC Form SC 13G filed by Frazier Lifesciences Acquisition Corporation
SC 13G - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1261dSEC
SEC Form 10-Q filed by Frazier Lifesciences Acquisition Corporation
10-Q - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)
1263dNEWS
$8.5 Million Bet On This Financial Services Stock? 4 Stocks Insiders Are Buying
Although US stocks closed higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Frazier Lifesciences Acquisition The Trade: Frazier Lifesciences Acquisition Corporation (NASDAQ:FLAC) 10% owner Sharon Rose Sha
1266dINSIDER
SEC Form 4: Viking Global Investors Lp bought $8,538,385 worth of shares (847,062 units at $10.08)
4 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1266dINSIDER
SEC Form 3: New insider Viking Global Investors Lp claimed ownership of 2,824,400 shares
3 - Frazier Lifesciences Acquisition Corp (0001828326) (Issuer)
1267d13D/G
SEC Form SC 13D filed by Frazier Lifesciences Acquisition Corporation
SC 13D - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)
1268d13D/G
SEC Form SC 13G filed by Frazier Lifesciences Acquisition Corporation
SC 13G - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)